BS3 Crosslinker
Based on 4 publication(s) in Google Scholar
BS3 Crosslinker is a cell-impermeable NHS ester crosslinker. BS3 Crosslinker "covalently locks" two spatially adjacent proteins on the surface of living cells into a covalent complex, and the dimerization/oligomerization status is determined by observing molecular weight shifts via Western blot. BS3 Crosslinker can crosslink EGFR and c-MET to assist in detecting and evaluating their dimerization status. It can be used in research related to oral cancer and glioblastoma.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.84%
- CAS 番号: 82436-77-9
- 分子式: C16H20N2O14S2
- 分子量:528.47
-
保管条件:
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
MedChemExpress(MCE)の使用を引用している文献 BS3 Crosslinker
More-
WB
生物活性
製品説明
体外実験
Guide (The following is our recommended protocol. This protocol serves only as a guideline and should be modified according to your specific needs.)
Assay for Detecting Receptor Dimerization on Live Cell Surfaces Using BS3 Crosslinking Method[1][2]
1. Experimental Principle: BS3 Crosslinker is a water-soluble, membrane-impermeable homobifunctional amine-reactive crosslinker. The sulfo-NHS ester groups at its two ends undergo nucleophilic substitution reactions with the ε-amino groups of lysine residues on the surfaces of adjacent proteins, forming stable amide bonds, thereby covalently linking two protein subunits with a spatial distance ≤ 11.4 Å. The reaction is performed at 4°C, which can effectively "freeze" transient or stable receptor dimers/oligomers on the cell membrane. Subsequently, the molecular weight shift (monomer → dimer → oligomer) is detected by SDS-PAGE and immunoblotting to determine the dimerization status of the target protein.
2. Reagent Preparation:
2.1 Warm the vial: Before opening the BS3 Crosslinker vial, allow it to return to room temperature to prevent moisture entry (condensation).
2.2 Prepare fresh solution immediately: Immediately before use, dissolve BS3 Crosslinker in cold water or amine-free buffer (e.g., PBS or 20 mM HEPES, pH 7.5). Do not store stock solutions.
2.3 Buffer selection: Use buffers with a pH of 7.0-8.5 (e.g., PBS at pH 7.4). Avoid buffers containing primary amines (such as Tris or glycine) as they react with the crosslinker.
3. Reaction Procedures
3.1 Mix components: Add the freshly prepared BS3 Crosslinker solution to the protein sample to achieve a 10- to 20-fold molar excess of BS3 Crosslinker relative to the protein.
3.2 Incubation: Incubate the mixture at room temperature for 30 minutes (if the protein requires lower temperature, perform the incubation on ice).
3.3 Quench the reaction: Add a quenching buffer containing primary amines (e.g., 25-50 mM Tris, pH 7.5-8.0) to terminate the reaction, followed by incubation at room temperature for 15 minutes.
3.4 Purification/cleanup: If required for downstream experiments, remove unreacted residual BS3 Crosslinker by dialysis or gel filtration.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 82436-77-9
-
性状 Solid
-
分子量 528.47
-
分子式 C16H20N2O14S2
-
Color White to off-white
-
SMILES
O=C(CCCCCCC(ON1C(C(CC1=O)S(=O)(O)=O)=O)=O)ON2C(C(CC2=O)S(=O)(O)=O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (4)
-
Journal Impact Factor
-
Most Recent
-
Int J Oral Sci
LncRNA EUDAL shapes tumor cell response to hypoxia-induced constitutive EGFR activation and promotes chemoresistance in oral cancer. [Abstract]2025 Sep 12;17(1):64. PMID: 40940319
BS3 Crosslinker purchased from MedChemExpress. Usage Cited in: Int J Oral Sci. 2025 Sep 12;17(1):64. [Abstract]
The EGFR dimerization assay of oral cancer cells with or without hypoxia treatment adopted BS3 Crosslinker disodium (BS3) as a cross-linking agent.
-
-
Biochem Biophys Res Commun
2026 Jul 30:824:153975. PMID: 42166810 -
溶剤 & 溶解度
体外:
DMSO : 175 mg/mL (331.14 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : 100 mg/mL (189.23 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (282 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Chen S, et al. LncRNA EUDAL shapes tumor cell response to hypoxia-induced constitutive EGFR activation and promotes chemoresistance in oral cancer. International journal of oral science. 2025 Sep 12;17(1):64. [Content Brief]
[2]. Wang Y, et al. S-palmitoylation of c-MET by CK2α-mediated zDHHC15 phosphorylation drives glioblastoma stem cell tumorigenicity. Neuro-oncology. 2025 Sep 17;27(8):1972-1986. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O / DMSO | 1 mM | 1.8923 mL | 9.4613 mL | 18.9226 mL | 47.3064 mL |
| 5 mM | 0.3785 mL | 1.8923 mL | 3.7845 mL | 9.4613 mL | |
| 10 mM | 0.1892 mL | 0.9461 mL | 1.8923 mL | 4.7306 mL | |
| 15 mM | 0.1262 mL | 0.6308 mL | 1.2615 mL | 3.1538 mL | |
| 20 mM | 0.0946 mL | 0.4731 mL | 0.9461 mL | 2.3653 mL | |
| 25 mM | 0.0757 mL | 0.3785 mL | 0.7569 mL | 1.8923 mL | |
| 30 mM | 0.0631 mL | 0.3154 mL | 0.6308 mL | 1.5769 mL | |
| 40 mM | 0.0473 mL | 0.2365 mL | 0.4731 mL | 1.1827 mL | |
| 50 mM | 0.0378 mL | 0.1892 mL | 0.3785 mL | 0.9461 mL | |
| 60 mM | 0.0315 mL | 0.1577 mL | 0.3154 mL | 0.7884 mL | |
| 80 mM | 0.0237 mL | 0.1183 mL | 0.2365 mL | 0.5913 mL | |
| 100 mM | 0.0189 mL | 0.0946 mL | 0.1892 mL | 0.4731 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.